.png)
SaaS
From emerging platform to pharmacy thought leader
The campaign delivered 101 earned media placements across outlets reaching a combined 399M audience, including multiple DA 90+ publications—placing Xevant alongside nationally recognized business and healthcare brands.
An SEO-first strategy generated 66 high-authority backlinks with a 42% placement link rate, creating durable digital equity that strengthens organic rankings and referral traffic beyond the immediate media window.
Strategic coverage in Forbes (81.5M audience), Newsweek (42.1M), and Entrepreneur (2.84M) positioned Xevant at the forefront of PBM transparency and retail pharmacy disruption—elevating enterprise credibility and industry authority simultaneously.
THE
CHALLENGE
Xevant, a health-tech company operating in the pharmacy services sector, needed to elevate its visibility and authority around PBM transparency, real-time data access, and prescription technology platforms.
The objective extended beyond awareness. Xevant needed to establish credibility with enterprise stakeholders, secure meaningful coverage in high-authority business and healthcare outlets, and build a durable digital footprint through backlinks and engagement that would compound over time.
Society22 PR was engaged to position Xevant as a trusted industry voice while delivering measurable media, SEO, and audience impact.
THE SOCIETY22
APPROACH
Society22 PR executed a multi-pronged strategy grounded in authority-building, narrative relevance, and metrics-driven performance.
High-authority media targeting
Rather than prioritizing volume, Society22 PR focused on securing placements in top-tier business and healthcare outlets with strong domain authority (DA 60+). This ensured credibility with investors, partners, and enterprise buyers while maximizing long-term digital value.
Narrative development and news relevance
Storytelling centered on timely, high-interest industry themes, including PBM transparency, drugstore retail disruption, and prescription-tech innovation. These narratives positioned Xevant at the intersection of healthcare policy, retail transformation, and data-driven pharmacy services.
SEO-first earned media strategy
Backlink acquisition was treated as a core campaign KPI. Coverage was evaluated not only on visibility, but on link value, domain authority, and referral potential—turning earned media into a lasting digital asset rather than a one-time hit.
Amplification and syndication
Select placements were extended through content syndication and social amplification, increasing reach beyond the primary publication audience and reinforcing thought leadership across channels.
THE
RESULTS
Coverage and reach (2023–present)
101 earned media placements across online, offline, and social channels
Coverage across outlets with a combined monthly audience of 399M
2.05M estimated impressions generated from secured placements
Average domain authority of 60, with multiple placements in DA 90+ publications
SEO and digital impact
42 of 101 placements included backlinks (42% link rate)
66 total backlinks generated from high-authority domains
Strong link acquisition rate supporting sustained organic visibility and referral traffic
Engagement and amplification
892 tracked social engagements (likes, comments, shares)
12 syndicated pieces extending reach beyond original placements
The Impact
Over the course of the engagement, Society22 PR placed Xevant into consistent, credible conversations across business and healthcare media.
The campaign delivered visibility at scale while simultaneously building long-term digital equity. High-authority backlinks strengthened search visibility, reinforced credibility with enterprise stakeholders, and created referral value that extends well beyond the coverage window.
By anchoring coverage in PBM transparency, retail pharmacy disruption, and prescription-tech innovation, Xevant emerged as a knowledgeable and trusted voice on industry trends shaping the future of pharmacy services.